Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High-content phenotypic profiling of drug response signatures across distinct cancer cells.

Molecular cancer therapeutics - 1 Jun 2010

Caie Peter D, Walls Rebecca E, Ingleston-Orme Alexandra, Daya Sandeep, Houslay Tom, Eagle Rob, Roberts Mark E, Carragher Neil O

Abstract excerpt

The application of high-content imaging in conjunction with multivariate clustering techniques has recently shown value in the confirmation of cellular activity and further characterization of drug mode of action following pharmacologic perturbation. However, such practical examples of phenotypic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Antineoplastic Agents
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cluster Analysis

Share to High-Throughput Screening Assays

Share to Image Processing, Computer-Assisted

Share to Neoplasms

Share to Principal Component Analysis

Source

Identifiers

PMID: 20530715
DOI: 10.1158/1535-7163.MCT-09-1148

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20530715-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High-content phenotypic profiling of drug response signatures across distinct cancer cells.PMID 20530715Read ↗

A robust high-content imaging approach for probing the mechanism of action and phenotypic outcomes of cell-cycle modulators.Semantic proximity Read ↗

High Content Phenotypic Profiling in Oesophageal Adenocarcinoma Identifies Selectively Active Pharmacological Classes of Drugs for Repurposing and Chemical Starting Points for Novel Drug DiscoverySemantic proximity Read ↗

Image-based multivariate profiling of drug responses from single cells.Semantic proximity Read ↗

Multidimensional Profiling of Drug-Treated Cells by Imaging Mass CytometrySemantic proximity Read ↗

Label-free morphometric profiling reveals early drug responses in 3D tumor spheroidsSemantic proximity Read ↗

Robust Classification of Small-Molecule Mechanism of Action Using a Minimalist High-Content Microscopy Screen and Multidimensional Phenotypic Trajectory Analysis.Semantic proximity Read ↗

A Computational Workflow for Cell Line Profiling by Imaging Mass Cytometry.Semantic proximity Read ↗

Development of a 3D Tissue Culture–Based High-Content Screening Platform That Uses Phenotypic Profiling to Discriminate Selective Inhibitors of Receptor Tyrosine KinasesSemantic proximity Read ↗

Comparison of methods for image-based profiling of cellular morphological responses to small-molecule treatment.Semantic proximity Read ↗

High-Content Phenotypic Profiling in Esophageal Adenocarcinoma Identifies Selectively Active Pharmacological Classes of Drugs for Repurposing and Chemical Starting Points for Novel Drug Discovery.Semantic proximity Read ↗

Linking phenotypes and modes of action through high-content screen fingerprints.Semantic proximity Read ↗

Evaluating Drug Response in 3D Triple Negative Breast Cancer Tumoroids with High Content Imaging and AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.